Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,295 | 284 | 88.9% |
| Education | $785.10 | 39 | 11.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $720.13 | 36 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $537.31 | 16 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $497.74 | 14 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $483.40 | 23 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $441.96 | 16 | $0 (2023) |
| Amgen Inc. | $347.29 | 21 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $314.40 | 13 | $0 (2023) |
| Vifor Pharma, Inc. | $302.03 | 15 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $275.41 | 16 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $257.08 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153.22 | 3 | Ardelyx, Inc. ($102.47) |
| 2023 | $1,276 | 50 | Mallinckrodt Hospital Products Inc. ($286.07) |
| 2022 | $1,577 | 70 | Aurinia Pharma U.S., Inc. ($332.43) |
| 2021 | $143.30 | 4 | Vifor Pharma, Inc. ($123.50) |
| 2020 | $317.78 | 18 | Mallinckrodt Hospital Products Inc. ($66.75) |
| 2019 | $1,283 | 64 | Mallinckrodt Enterprises LLC ($232.21) |
| 2018 | $1,408 | 58 | Otsuka America Pharmaceutical, Inc. ($307.37) |
| 2017 | $921.45 | 56 | Actelion Pharmaceuticals US, Inc. ($118.06) |
All Payment Transactions
323 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/15/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $50.38 | General |
| Category: Renal Denervation System | ||||||
| 03/28/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $102.47 | General |
| Category: NEPHROLOGY | ||||||
| 08/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Rare Disease | ||||||
| 08/21/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Nephrology | ||||||
| 08/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardio-renal | ||||||
| 08/16/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: NEPHROLOGY | ||||||
| 08/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardio-renal | ||||||
| 08/10/2023 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Hyperkalemia | ||||||
| 07/31/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/25/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Nephrology | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Nephrology | ||||||
| 07/13/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Nephrology | ||||||
| 06/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardio-renal | ||||||
| 06/23/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Rare Disease | ||||||
| 06/21/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.65 | General |
| Category: NEPHROLOGY | ||||||
| 05/29/2023 | Aurinia Pharma U.S., Inc. | — | Food and Beverage | In-kind items and services | $130.67 | General |
| 05/15/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.35 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/11/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,355 | 3,144 | $569,626 | $283,861 |
| 2022 | 13 | 1,298 | 2,976 | $530,669 | $263,685 |
| 2021 | 13 | 1,292 | 2,947 | $491,971 | $250,729 |
| 2020 | 14 | 1,314 | 3,270 | $499,861 | $258,956 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 305 | 1,406 | $146,224 | $85,182 | 58.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 34 | 177 | $101,598 | $47,464 | 46.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 20 | 141 | $67,116 | $30,700 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 364 | 450 | $60,300 | $26,591 | 44.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 166 | 204 | $40,392 | $20,275 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 168 | $32,088 | $14,357 | 44.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 138 | $20,562 | $12,552 | 61.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 21 | 55 | $26,180 | $12,326 | 47.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $17,290 | $7,912 | 45.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 61 | $17,751 | $7,842 | 44.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 41 | 126 | $14,616 | $6,927 | 47.4% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 11 | 31 | $10,137 | $4,763 | 47.0% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 13 | 36 | $4,968 | $2,344 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 42 | $4,116 | $1,909 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $2,376 | $1,025 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 15 | $2,160 | $972.79 | 45.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 12 | $1,752 | $720.53 | 41.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 273 | 1,205 | $125,320 | $66,204 | 52.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 24 | 123 | $70,602 | $34,078 | 48.3% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 21 | 136 | $64,736 | $31,302 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 383 | 495 | $66,330 | $29,071 | 43.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 162 | 185 | $53,835 | $28,063 | 52.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 93 | 261 | $38,889 | $20,640 | 53.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 17 | 49 | $23,324 | $11,119 | 47.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 77 | 94 | $18,612 | $9,841 | 52.9% |
About Dr. Anil Muddada, M.D
Dr. Anil Muddada, M.D is a Internal Medicine healthcare provider based in Lima, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1386877751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil Muddada, M.D has received a total of $7,080 in payments from pharmaceutical and medical device companies, with $153.22 received in 2024. These payments were reported across 323 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($6,295).
As a Medicare-enrolled provider, Muddada has provided services to 5,259 Medicare beneficiaries, totaling 12,337 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Lima, OH
- Active Since 09/01/2009
- Last Updated 06/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1386877751
Products in Payments
- ACTHAR (Biological) $1,021
- JYNARQUE (Drug) $539.11
- Kerendia (Drug) $314.40
- LUPKYNIS (Drug) $276.84
- SAMSCA (Drug) $255.41
- INJECTAFER (Drug) $254.28
- Veltassa (Drug) $232.86
- Velphoro (Drug) $213.08
- TARPEYO (Drug) $161.85
- GATTEX (Drug) $161.28
- Auryxia (Drug) $159.34
- Parsabiv (Biological) $150.57
- FARXIGA (Drug) $146.75
- FERAHEME (Drug) $145.61
- Rayaldee (Drug) $139.18
- RAYALDEE (Drug) $136.23
- LOKELMA (Drug) $130.94
- XARELTO (Drug) $127.85
- PURIFIED CORTROPHIN GEL (Drug) $126.54
- FASENRA (Drug) $125.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lima
Dr. Jason Stienecker, D.o, D.O
Internal Medicine — Payments: $358,360
Sandeep Patel, Md, MD
Internal Medicine — Payments: $176,472
Jayde Kurland, Md, MD
Internal Medicine — Payments: $35,884
Kishore Nallu, M.d, M.D
Internal Medicine — Payments: $14,690
Dr. Scott Rinesmith, M.d, M.D
Internal Medicine — Payments: $13,019
Dr. Jill Hemmelgarn, D.o, D.O
Internal Medicine — Payments: $5,272